Further studies are required to investigate the mechanisms how TLR2 incorporation promote CAR T cells to infiltrate into tumors and disrupt tumor microenvironment, which are the major challenges for treating CNS and extramedullary leukemia. The gene discussed is TLR2; the disease is neoplasm.